Christopher Beck's Story of Recurrences, High-Dose Chemo, and Clinical Trials
Christopher Beck's Story of Recurrences, High-Dose Chemo, and Clinical Trials
Episode 93
Editor’s Note: Since this episode was published, we were saddened to learn of Christopher’s passing in December 2025. We are deeply grateful to Christopher for sharing his story on the podcast and for the strength, honesty, and hope he brought to our testicular cancer community. Our thoughts are with his family and loved ones.
In this episode of It Takes Balls, 29-year-old Christopher Beck shares his intense and ongoing fight against a rare and aggressive form of testicular cancer - one that didn’t even begin in his testicle.
Christopher opens up about the strange onset of symptoms that eventually led to a stunning diagnosis: embryonal carcinoma presenting as a retroperitoneal mass. Despite having no tumors in his testicles, pathology confirmed testicular cancer, placing him in a rare category of patients with extragonadal germ cell tumors.
What follows is a relentless journey: four rounds of BEP chemotherapy, followed by a post-chemo RPLND at Indiana University. Christopher thought he was in the clear until new scans revealed a recurrence a few months later. What began as one battle turned into two, then three. He entered a clinical trial and underwent high-dose chemotherapy with stem cell rescue.
Now, Christopher is enrolled in a cutting-edge CAR T-cell therapy trial - a hopeful step forward. He shares candid reflections on the mental weight of recurrence, the isolation of dealing with a rare cancer, and the importance of keeping faith while making space for both grief and gratitude.
Christopher also speaks openly about how cancer reshaped his identity, tested his relationships, and pushed him to live more deliberately, with purpose, presence, and patience.
Click the links below to listen:
